Crossfund Sicav-Cross.Healthcare Fd.A/ LU1334634299 /
NAV22/08/2024 | Chg.+0.5900 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
176.9500USD | +0.33% | reinvestment | Equity Worldwide | FundPartner Sol.(EU) ▶ |
Performance mensuelle
janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021 | 0.73 | 0.35 | 0.27 | 4.65 | -0.99 | 2.47 | 3.15 | 1.85 | -4.61 | 3.90 | -4.19 | 5.94 | +13.73% |
2022 | -7.83 | -1.45 | 4.13 | -5.42 | -0.08 | -2.09 | 2.26 | -5.73 | -2.78 | 8.33 | 2.54 | 0.01 | -8.88% |
2023 | -2.01 | -3.06 | 1.76 | 3.74 | -3.93 | 3.55 | -0.14 | -1.13 | -2.87 | -5.81 | 4.36 | 6.08 | -0.24% |
2024 | 3.10 | 2.52 | 2.60 | -4.63 | 2.31 | 2.63 | 1.36 | 3.56 | - | - | - | - | - |
Valeurs calculées
CAD | 6 Mois | 1 An | 3 Ans | 5 Ans | |
---|---|---|---|---|---|
Volatilité | 10.64% | 11.04% | 10.91% | 12.69% | -% |
Ratio de Sharpe | 1.81 | 0.93 | 1.08 | -0.17 | - |
Le meilleur mois | +6.08% | +3.56% | +6.08% | +8.33% | - |
Le plus défavorable mois | -4.63% | -4.63% | -5.81% | -7.83% | - |
Perte maximale | -6.39% | -6.39% | -10.90% | -19.31% | - |
Surperformance | - | - | - | - | - |
Toutes les cotations dans USD
Tranches
Nom | Type de rendement | Prix de rachat | 1 An | 3 Ans | |
---|---|---|---|---|---|
Crossfund Sicav-Cross.Healthcare... | reinvestment | 142.5600 | +11.10% | -5.31% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 150.6300 | +13.85% | -1.56% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 176.9500 | +15.34% | +4.29% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 139.2100 | +10.69% | -6.37% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 172.2000 | +15.05% | +3.23% | |
CROSSFUND SICAV - Crossinvest He... | reinvestment | 146.9300 | +13.40% | -2.71% |
Performance
CAD | +13.98% | ||
---|---|---|---|
6 Mois | +6.64% | ||
1 An | +15.34% | ||
3 Ans | +4.29% | ||
5 Ans | - | ||
10 ans | - | ||
Depuis le début | +18.15% | ||
Année | |||
2023 | -0.24% | ||
2022 | -8.88% | ||
2021 | +13.73% |